APLM
Apollomics Inc.
Latest Form 4:Purchase$300KbyChen Yi-Kuei (Chief Operating Officer) · filed Aug 17, 2026
Apollomics Inc. (APLM) has 13 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 25, 2026.
Insiders have net bought $8.3M over the trailing 6 months. The largest single insider purchase in this window was $7.6M by Chief Executive Officer Chen Hung-Wen on Aug 14, 2026.
- Industry:Biotechnology
- CEO:Hung-Wen Chen
- Employees:13
- HQ:Foster City, CA, US
- IPO:2021-11-26
Insider Buying
$8.3M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$58.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Chen Yi-KueiFirst filing | Chief Operating Officer | Purchase | 20,000 | $300K | Aug 17 | SEC ↗ |
LIN PETER KUAN-HOWFirst filing | Chief Financial Officer | Purchase | 26,667 | $400K | Aug 17 | SEC ↗ |
Chen Hung-WenFirst filing | Chief Executive Officer | Purchase | 536,667 | $7.6M | Aug 17 | SEC ↗ |
Related companies
Apollomics Inc. is in the Healthcare sector.